首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Kassir Mahmood,Jude Allen,Rebecca Varley et al. Kassir Mahmood et al.
Not taking immunosuppressive medication as directed is strongly correlated with late acute rejection, which is often severe, leading to progressive loss of transplant function and poor outcomes overall.
Yue-Xin Lu,Bao-Jie Mao,Ming Wang et al. Yue-Xin Lu et al.
Background: The neutrophil percentage-to-albumin ratio (NPAR) is an emerging inflammatory biomarker that has demonstrated a significant association with poor outcomes in patients with cardiovascular diseases.
Suzan Suliman Alhumaidi,Fahad Abdulrahman Algaeed,Meshari Fayez Aladhadh et al. Suzan Suliman Alhumaidi et al.
Unlike those in other studies, variants c.65C>A and c.134C>A were associated with poor outcomes and early presentation with metabolic decompensation.
Wenwen Ji,Guangdong Wang,Tingting Liu et al. Wenwen Ji et al.
BackgroundThe incidence of acute kidney injury (AKI) is increased in patients with community-acquired pneumonia (CAP), contributing to poor outcomes in ICUs. Early identification of patients at high risk for AKI is essential for timely intervention.
Takaaki Konuma,Yoshimitsu Shimomura,Shohei Mizuno et al. Takaaki Konuma et al.
Primary refractory acute myeloid leukaemia (AML) remains a major clinical challenge, with poor outcomes despite salvage chemotherapy. Allogeneic haematopoietic cell transplantation (HCT) continues to be a potentially curative option for these patients.
Elizabeth Cray,Nida Javed Hayat,Chi Ho Song et al. Elizabeth Cray et al.
Identifying whether frailty is a risk factor for poor outcomes may facilitate clinical decision making and direct care appropriately.
Christina Moe,Jasmine Zain Christina Moe
Treatments based on paradigms for aggressive B cell lymphomas have yielded poor outcomes and there is an immense need for therapies that are directed towards PTCL.
Simone Ferrero,Simone Ragaini Simone Ferrero
Above all, TP53 disruption remains the major adverse factor, associated with poor outcomes despite new combination therapies. Although recent clinical trials are exploring innovative targeted strategies, the effective management of high-risk MCL remains challenging till now.
Chanjuan Wei,Ying Yang,Yahui Hu et al. Chanjuan Wei et al.
Background: Few studies have investigated the correlation between serum liver function indices and clinical outcomes in acute ischemic stroke (AIS) patients. ...
耗时 0.23166 秒,为您在 48229835 条记录里面共找到 10000 篇文章 [XML]